Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression
Azmeraw T. Amare, Klaus Oliver Schubert, Fasil Tekola‐Ayele, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 1, pp. 35-45
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 230
Depression and cardiovascular disease: The deep blue sea of women's heart
Valentina Bucciarelli, Anna Laura Caterino, Francesco Bianco, et al.
Trends in Cardiovascular Medicine (2019) Vol. 30, Iss. 3, pp. 170-176
Open Access | Times Cited: 165
Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder
Fuquan Zhang, Shuquan Rao, Hongbao Cao, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 3
Open Access | Times Cited: 58
Clinical utility of polygenic risk scores: a critical 2023 appraisal
Sebastian Koch, Jörg Schmidtke, Michael Krawczak, et al.
Journal of Community Genetics (2023) Vol. 14, Iss. 5, pp. 471-487
Open Access | Times Cited: 35
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Xiying Fu, Yicun Wang, Fangyi Zhao, et al.
Aging (2023)
Open Access | Times Cited: 31
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review
Julia J. Meerman, Sophie E. ter Hark, Joost Janzing, et al.
Journal of Affective Disorders (2022) Vol. 304, pp. 1-11
Open Access | Times Cited: 36
Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?
Laura Fusar‐Poli, Bart P. F. Rutten, Jim van Os, et al.
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 663-675
Open Access | Times Cited: 36
The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases
Marco Salluzzo, Clara Vianello, Sandra Abdullatef, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1886-1886
Open Access | Times Cited: 13
Pharmacogenomic scores in psychiatry: systematic review of current evidence
Nigussie Tadesse Sharew, Scott Clark, Klaus Oliver Schubert, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Cardiovascular Risk Predicts White Matter Hyperintensities, Brain Atrophy and Treatment Resistance in Major Depressive Disorder: Role of Genetic Liability
Marco Paolini, Melania Maccario, V. Saredi, et al.
Acta Psychiatrica Scandinavica (2025)
Open Access
A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics
Danielle Johnson, MacKenzie A.P. Wilke, Sarah M. Lyle, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 4, pp. 919-930
Open Access | Times Cited: 32
Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders
Xinyuan Zhang, Anastasia Lucas, Yogasudha Veturi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review
Tian-Wen Lou, Borui Tao, Ming Chen
Neuroscience (2023) Vol. 514, pp. 123-140
Closed Access | Times Cited: 10
Transcriptome Changes in Relation to Manic Episode
Ya-Chin Lee, Yu-Lin Chao, Chiao-Erh Chang, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 23
Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder
Rongrong Zhu, Qian Cheng, Xiaolie He, et al.
Neural Regeneration Research (2020) Vol. 16, Iss. 3, pp. 537-537
Open Access | Times Cited: 23
Shared genetics between classes of obesity and psychiatric disorders: A large-scale genome-wide cross-trait analysis
Hui Ding, Mengyuan Ouyang, Jinyi Wang, et al.
Journal of Psychosomatic Research (2022) Vol. 162, pp. 111032-111032
Closed Access | Times Cited: 13
Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant Treatment
Lucia Carboni, Francesca Pischedda, Giovanni Piccoli, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1818-1818
Open Access | Times Cited: 20
Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities
Song Zhai, Devan V. Mehrotra, Judong Shen
Briefings in Bioinformatics (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 6
From Bound Cells Comes a Sound Mind: The Role of Neuronal Growth Regulator 1 in Psychiatric Disorders
Kyungchul Noh, Jung-Cheol Park, Jung‐Soo Han, et al.
Experimental Neurobiology (2020) Vol. 29, Iss. 1, pp. 1-10
Open Access | Times Cited: 17
Antidepressant treatment outcomes in patients with and without comorbid physical or psychiatric disorders: A systematic review and meta-analysis
Helena K. Kim, Daniel M. Blumberger, Paul B. Fitzgerald, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 225-234
Closed Access | Times Cited: 15
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study
Maria Laura Ricardo-Silgado, Sneha Singh, Lizeth Cifuentes, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study
Samar S. M. Elsheikh, Victoria S. Marshe, Xiaoyu Men, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 1
Systemic Catecholaminergic Deficiency in Depressed Patients with and without Coronary Artery Disease
Uta Hoppmann, Harald Engler, Sabrina Krause, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 986-986
Open Access | Times Cited: 7
Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study
Katrine Kveli Fjukstad, Lavinia Athanasiu, Shahram Bahrami, et al.
The Pharmacogenomics Journal (2021) Vol. 21, Iss. 5, pp. 574-585
Closed Access | Times Cited: 7
Association of heat shock protein polymorphisms with patient susceptibility to coronary artery disease comorbid depression and anxiety in a Chinese population
Haidong Wang, Yudong Ba, Wenxiu Han, et al.
PeerJ (2021) Vol. 9, pp. e11636-e11636
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top